GLAUKOS CORP (GKOS)
US3773221029 - Common Stock
Taking everything into account, GKOS scores 3 out of 10 in our fundamental rating. GKOS was compared to 192 industry peers in the Health Care Equipment & Supplies industry. The financial health of GKOS is average, but there are quite some concerns on its profitability. GKOS is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
GKOS had negative earnings in the past year.
In the past year GKOS has reported a negative cash flow from operations.
GKOS had negative earnings in 4 of the past 5 years.
GKOS had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
GKOS has a Return On Assets of -14.32%. This is comparable to the rest of the industry: GKOS outperforms 58.33% of its industry peers.
GKOS has a Return On Equity (-29.16%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.32% | ||
| ROE | -29.16% | ||
| ROIC | N/A |
ROA(3y)-9.65%
ROA(5y)-7.8%
ROE(3y)-18.78%
ROE(5y)-14.41%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 75.99%, GKOS belongs to the top of the industry, outperforming 86.98% of the companies in the same industry.
GKOS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for GKOS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.99% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.68%
GM growth 5Y-2.48%
2. Health
2.1 Basic Checks
GKOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GKOS has more shares outstanding
The number of shares outstanding for GKOS has been increased compared to 5 years ago.
Compared to 1 year ago, GKOS has a worse debt to assets ratio.
2.2 Solvency
GKOS has an Altman-Z score of 5.36. This indicates that GKOS is financially healthy and has little risk of bankruptcy at the moment.
GKOS has a better Altman-Z score (5.36) than 80.21% of its industry peers.
GKOS has a Debt/Equity ratio of 0.77. This is a neutral value indicating GKOS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.77, GKOS is doing worse than 74.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.36 |
ROIC/WACCN/A
WACC9.69%
2.3 Liquidity
A Current Ratio of 5.34 indicates that GKOS has no problem at all paying its short term obligations.
GKOS has a Current ratio of 5.34. This is in the better half of the industry: GKOS outperforms 71.88% of its industry peers.
A Quick Ratio of 4.78 indicates that GKOS has no problem at all paying its short term obligations.
GKOS's Quick ratio of 4.78 is fine compared to the rest of the industry. GKOS outperforms 75.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.34 | ||
| Quick Ratio | 4.78 |
3. Growth
3.1 Past
GKOS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.65%.
GKOS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.26%.
GKOS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.66% yearly.
EPS 1Y (TTM)-3.65%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-18.87%
Revenue 1Y (TTM)11.26%
Revenue growth 3Y11.83%
Revenue growth 5Y11.66%
Revenue growth Q2Q15.63%
3.2 Future
Based on estimates for the next years, GKOS will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.32% on average per year.
GKOS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.54% yearly.
EPS Next Y6.23%
EPS Next 2Y19.25%
EPS Next 3Y23.93%
EPS Next 5Y17.32%
Revenue Next Year14.57%
Revenue Next 2Y19.59%
Revenue Next 3Y22.1%
Revenue Next 5Y16.54%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for GKOS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GKOS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
GKOS's earnings are expected to grow with 23.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.25%
EPS Next 3Y23.93%
5. Dividend
5.1 Amount
No dividends for GKOS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GLAUKOS CORP
NYSE:GKOS (5/1/2024, 7:04:01 PM)
After market: 97 -1.91 (-1.93%)98.91
+2.91 (+3.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.89B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.32% | ||
| ROE | -29.16% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.99% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.34 | ||
| Quick Ratio | 4.78 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-3.65%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y6.23%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)11.26%
Revenue growth 3Y11.83%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y